To initially test the effect of inhibiting the JAK/STAT3 pathway on tumor properties, we developed a high-content 3D tumorsphere drug-screening assay to construct high-resolution concentration-response curves following treatment with the individual JAK/STAT3 inhibitors pacritinib and AZD1480 in vitro (Fig. 3a). This evidence concerns the gene STAT3 and neoplasm.